Dr. Charles Perou, from the UNC Lineberger Comprehensive Cancer Center, on Next Generation Sequencing Technology
OncLive TV
Dr. Supriya Mohile from the University of Rochester Medical Center Discusses Prostate Cancer in Elderly Patients
Advertisement
Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Treating Breast Cancer Bone Metastases
Dr. Andrew Zelenetz, from Memorial Sloan-Kettering Cancer Center, on Targeted Therapies for Diffuse Large B-cell Lymphoma
Dr. Edith Perez, from the Mayo Clinic Cancer Center, Discusses Adjuvant Chemotherapy Patient Selection
Dr. Harry Erba, from the University of Michigan Health System, Discusses the Frontline Treatment of CML
Advertisement
Dr. Matthew Ellis, from Siteman Cancer Center, Describes Breast Cancer Heterogeneity
Dr. Neil Spector, from the Duke Cancer Institute, Discusses the Complexities of Cancer
Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses ABC DLBCL Research
Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, Discusses Breast Cancer Chemoprevention
Dr. Jenny Chang, from the Methodist Cancer Center, Discusses Combining HER2 Targeted Therapies
Dr. Elizabeth Gore, from the Medical College of Wisconsin, Discusses Hypofractionated Radiotherapy
Dr. Patrick Borgen, from the Maimonides Breast Cancer Center, Discusses the Negative Effects of Pinkwashing
Dr. William Wierda, from the MD Anderson Cancer Center, Discusses Watchful Waiting in CLL
Dr. Roman Perez-Soler, from Albert Einstein College of Medicine, on the Future of Lung Cancer Therapies
Dr. Sundar Jagannath, from Mount Sinai Medical Center, Discusses the VANTAGE Trials
Dr. Freya Schnabel from NYU School of Medicine Discusses the DCIS Recurrence Score
Dr. Harold Harvey from Penn State Hershey Cancer Institute Discusses Preventing Breast Cancer
Dr. Stephen Ansell from the Mayo Clinic in Minnesota Describes Waldenstrom Macroglobulinemia Symptoms
Dr. Chandra Belani from Penn State Hershey Cancer Institute Discusses Driver Mutations in NSCLC
Dr. Sridhar Ramaswamy from the Massachusetts General Hospital Cancer Center Discusses Tumor Heterogeneity
Dr. Jose Baselga from Massachusetts General Hospital Discusses the BOLERO Breast Cancer Trials
Dr. William Wierda, from MD Anderson Cancer Center, on Diagnosing Chronic Lymphocytic Leukemia
Dr. Ruben Mesa from the Mayo Clinic in Arizona Discusses JAK Inhibitors for Myelofibrosis
Dr. Michael Birrer from Massachusetts General Hospital Cancer Center on the Ovarian Cancer Avastin OS Benefit
Dr. Leonard Gomella from the Jefferson Kimmel Cancer Center on the Cost of the Immunotherapy Sipuleucel-T
Dr. Sundar Jagannath from the Tisch Cancer Institute Discusses HDAC Inhibitors for Multiple Myeloma
Dr. Lawrence Solin from Einstein Medical Center on Personalizing Treatment With the DCIS Score
Dr. Daniel Petrylak, from the Herbert Irving Comprehensive Cancer Center, Discusses the Isotope Radium-223
Dr. Howard Burris from Sarah Cannon Research Institute Discusses Recurrence Scores Predicting pCR
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5